Universal Beteiligungs und Servicegesellschaft mbH Sells 11,258 Shares of HCA Healthcare, Inc. $HCA

Universal Beteiligungs und Servicegesellschaft mbH trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 8.0% in the fourth quarter, Holdings Channel reports. The firm owned 128,622 shares of the company’s stock after selling 11,258 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in HCA Healthcare were worth $60,253,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. Sovran Advisors LLC grew its stake in HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock valued at $1,063,000 after purchasing an additional 22 shares in the last quarter. Centerpoint Advisors LLC grew its stake in HCA Healthcare by 11.0% in the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock valued at $95,000 after purchasing an additional 22 shares in the last quarter. Cary Street Partners Financial LLC grew its stake in HCA Healthcare by 3.9% in the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after purchasing an additional 22 shares in the last quarter. Angeles Wealth Management LLC grew its stake in HCA Healthcare by 2.4% in the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after purchasing an additional 24 shares in the last quarter. Finally, One Capital Management LLC grew its stake in HCA Healthcare by 1.1% in the third quarter. One Capital Management LLC now owns 2,250 shares of the company’s stock valued at $959,000 after purchasing an additional 24 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. The trade was a 8.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 15,214 shares of company stock valued at $7,797,595 over the last 90 days. 1.50% of the stock is currently owned by insiders.

HCA Healthcare Trading Up 0.2%

NYSE:HCA opened at $472.07 on Thursday. The stock has a market cap of $105.54 billion, a P/E ratio of 16.63, a PEG ratio of 1.45 and a beta of 1.36. The stock has a 50 day simple moving average of $508.81 and a 200 day simple moving average of $485.14. HCA Healthcare, Inc. has a 1-year low of $321.39 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the firm posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.17 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th were issued a $0.78 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $3.12 annualized dividend and a yield of 0.7%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is presently 10.99%.

Analysts Set New Price Targets

Several research analysts have recently commented on HCA shares. KeyCorp set a $503.00 target price on HCA Healthcare in a research note on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft lifted their target price on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. JPMorgan Chase & Co. lifted their target price on HCA Healthcare from $420.00 to $535.00 and gave the stock a “neutral” rating in a research note on Friday, February 20th. Leerink Partners lifted their target price on HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Finally, TD Cowen lifted their price target on HCA Healthcare from $529.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, March 10th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $537.36.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.